LITTLE KNOWN FACTS ABOUT MBL77.

Latest molecular scientific tests have presented lots of insights into the procedures that govern the event and progression of CLL, together with many novel mutated genes clustered in several functional pathways. The CLL epigenome is reprogrammed with the modulation of regulatory areas that seem de novoSomatic mutations in chromatin remodeler genes